Segment-specific targeting via RNA interference mediates down-regulation of OPN expression in hepatocellular

F Lin1, C M Huang2, J Cao3

  • 1Department of General Surgery, Guangzhou First People's Hospital Affiliated to Guangzhou Medical University, Guangzhou, Guangdong, China.

Insights

Researchers investigated RNA interference (RNAi) molecules targeting osteopontin (OPN) in hepatocellular carcinoma (HCC) cells. They identified specific small interfering RNAs (siRNAs) that effectively reduce OPN expression, potentially inhibiting tumor metastasis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Therapy

Background:

  • Osteopontin (OPN) is implicated in hepatocellular carcinoma (HCC) metastasis and recurrence post-surgery.
  • Targeting OPN expression is a potential strategy to combat HCC invasiveness.

Purpose of the Study:

  • To evaluate the efficacy of RNA interference (RNAi) molecules targeting different segments of OPN for gene knockdown.
  • To identify the most effective siRNA sequence for down-regulating OPN expression in HCC cells.

Main Methods:

  • Synthesis of three distinct small interfering RNAs (siRNAs A, B, and C) targeting OPN.
  • Transfection of siRNAs into the HEP-G2 HCC cell line.
  • Quantification of OPN mRNA and protein levels using fluorescent quantitative PCR and immunohistochemistry.

Main Results:

  • All tested siRNAs demonstrated a down-regulatory effect on OPN expression at both mRNA and protein levels.
  • siRNA-A exhibited a more significant reduction in OPN mRNA and protein compared to siRNAs B and C.
  • Post-transfection, OPN mRNA levels increased in ΔCT values (OPNi-A: 12.14 ± 1.43; OPNi-B: 10.22 ± 1.97; OPNi-C: 10.48 ± 1.88) and protein scores decreased (OPNi-A: 2.84 ± 1.52; OPNi-B: 4.43 ± 1.65; OPNi-C: 3.95 ± 1.43).

Conclusions:

  • Different siRNA sequences targeting specific OPN gene segments yield varying degrees of gene silencing efficacy.
  • Targeted siRNA synthesis against optimal OPN segments holds promise for managing HCC cell invasiveness and metastasis.

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
8.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.6K
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
28.6K
RNA Interference01:23

RNA Interference

7.8K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
4.0K